Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride: Case report

Ryuta Saito, Yukihiko Sonoda, Toshihiro Kumabe, Ken Ichi Nagamatsu, Mika Watanabe, Teiji Tominaga

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Abstract

This 13-year-old boy with a history of cranial irradiation for the CNS recurrence of acute lymphocytic leukemia developed a glioblastoma in the right cerebellum. Resection and chemo- and radiotherapy induced remission of the disease. However, recurrence was noted in the brainstem region 8 months later. Because no effective treatment was available for this recurrent lesion, the authors decided to use convection-enhanced delivery (CED) to infuse nimustine hydrochloride. On stereotactic insertion of the infusion cannula into the brainstem lesion, CED of nimustine hydrochloride was performed with real-time MR imaging to monitor the co-infused chelated gadolinium. The patient's preinfusion symptom of diplopia disappeared after treatment. Follow-up MR imaging revealed the response of the tumor. The authors report on a case of recurrent glioblastoma infiltrating the brainstem that regressed after CED of nimustine hydrochloride.

Original languageEnglish
Pages (from-to)522-526
Number of pages5
JournalJournal of Neurosurgery: Pediatrics
Volume7
Issue number5
DOIs
Publication statusPublished - 2011 May

Keywords

  • Brainstem
  • Convection-enhanced delivery
  • Gadolinium
  • Glioblastoma
  • Nimustine hydrochloride

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride: Case report'. Together they form a unique fingerprint.

Cite this